NCT06813859 Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device
| NCT ID | NCT06813859 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Balgrist University Hospital |
| Condition | Fetal Distress |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-06-30 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-06-30 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Effect of acute exercise testing in pregnant athletes on maternal and fetal heart rate, fetal/maternal bloodflow and cardiotocogramm assessment.
Eligibility Criteria
Inclusion Criteria: * Presence of signed informed consent form * healthy pregnant active female over the age of 18 years and below 45 years * sporting activity \>4h/week on 2 or more weekdays * single pregnancy, between 28+0 and 34+0 weeks of pregnancy Exclusion Criteria: * No signed informed consent form or revocation of consent * pre-existing pregnancy complications
Contact & Investigator
Johannes Scherr, Prof. Dr. med.
STUDY CHAIR
University Centre for Prevention and Sports Medicine, Department of Orthopaedics, Balgrist University Hospital, University of Zurich, Zurich, Switzerland
Frequently Asked Questions
Who can join the NCT06813859 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Fetal Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06813859 currently recruiting?
Yes, NCT06813859 is actively recruiting participants. Contact the research team at nora.wieloch@balgrist.ch for enrollment information.
Where is the NCT06813859 trial being conducted?
This trial is being conducted at Zurich, Switzerland, Zurich, Switzerland.
Who is sponsoring the NCT06813859 clinical trial?
NCT06813859 is sponsored by Balgrist University Hospital. The principal investigator is Johannes Scherr, Prof. Dr. med. at University Centre for Prevention and Sports Medicine, Department of Orthopaedics, Balgrist University Hospital, University of Zurich, Zurich, Switzerland. The trial plans to enroll 20 participants.